Robuta

https://www.techtransfer.nih.gov/patent/e-146-1999-0-us-01 Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of... of the reduction nonspecific animal toxicity https://www.patlynk.com/trial/NCT00001271 A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive... Patients with CD22(+) B-cell lymphomas will be treated with escalating doses as a 192 hr infusion of immunotoxin in a Phase I study to determine dose limiting t phase i study continuous infusion immunotoxin igg smpt https://www.techtransfer.nih.gov/patent/e-157-2016-0-us-01 New, More Stable Immunotoxin Variants With A Disulfide Bond Protecting The Furin Cleavage Site |... furin cleavage site disulfide bond new stable immunotoxin https://www.techtransfer.nih.gov/patent/e-147-1991-0-au-09 RECOMBINANT IMMUNOTOXIN | Technology Transfer technology transfer recombinant immunotoxin https://www.techtransfer.nih.gov/patent/e-117-2011-0-ph-15 Recombinant Immunotoxin Targeting Mesothelin | Technology Transfer technology transfer recombinant immunotoxin targeting mesothelin https://www.techtransfer.nih.gov/patent/e-001-1991-0-jp-06 Recombinant Immunotoxin Composed of a Single Chain Antibody Reacting With The Human Transferrin... composed of a single with the recombinant immunotoxin